Profusa Announces Strategic Partnership with Leading Greek Vascular Surgeon
On January 8, 2026, Profusa, Inc. (Nasdaq: PFSA), a commercial-stage digital health company based in Berkeley, California, revealed a significant collaboration with Dr. Theodosios Bisdas, a prominent vascular surgeon from Athens Medical Center in Greece. This partnership marks a notable step in advancing the application of innovative medical technology for continuous biochemical monitoring.
Collaboration Details: Integration of Lumee™ Oxygen Monitoring
The agreement centers around the adoption of Lumee™ Oxygen tissue monitoring technology in Dr. Bisdas's clinical practice. This state-of-the-art system will be utilized both in patient care and ongoing clinical studies aimed at enhancing home monitoring capabilities. Dr. Bisdas expressed enthusiasm about the integration, stating, “Having used the Lumee Oxygen tissue monitoring in clinical trials, I look forward to integrating the technology in our practice at the Athens Medical Center.”
Dr. Bisdas's Expertise and Contributions
Dr. Bisdas is widely recognized for his expertise in endovascular techniques and has previously served as an Associate Professor for Vascular Surgery at Universitätsklinikum Münster in Germany. With extensive involvement in major research projects, he has been instrumental as the principal investigator in the CRITISCH Registry, the largest open multicenter study in German vascular surgery focused on treating critical ischemia and diabetic foot conditions.
Beyond his clinical practice, Dr. Bisdas is a noted educator and advisor to various medical technology firms, contributing valuable insights into new vascular prostheses technologies. His prolific output includes over 100 scientific publications and involvement in the planning and execution of numerous international medical conferences.
Future Implications of the Partnership
Ben Hwang, Ph.D., Chairman and CEO of Profusa, emphasized the significance of this collaboration, stating, “We welcome Dr. Bisdas to our roster of vascular surgeons as we continue to expand our network.” This partnership not only enhances the capabilities at the Athens Medical Center but also opens avenues for future clinical research on additional vascular applications of Profusa's technology.
About Profusa
Profusa, Inc. is at the forefront of digital health innovation, developing next-generation tissue-integrated sensors. These sensors are designed to provide actionable medical data continuously, promoting effective personal and medical health management. With products like Lumee™ and a robust data platform, Profusa aims to furnish reliable biochemical profiles that clinicians can trust.
Contact Information
For further inquiries, please reach out via email at info@coreir.com or call 1 (212) 655-0924.
Forward-Looking Statements
This announcement may contain forward-looking statements that relate to future performance and operations of Profusa. Such statements involve risks and uncertainties; actual results may differ significantly. For more details, refer to the company’s filings with the SEC.